NDC 80425-0316-01 - Doxepin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0316
- Requested NDC
- 80425-0316-01
- Package NDCs from labels
- 80425-0316-1, 80425-0316-2, 80425-0316-3, 80425-0316-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Doxepin Hydrochloride - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0316-1 | Doxepin Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | 2 | |
| 80425-0316-2 | Doxepin Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | 2 | |
| 80425-0316-3 | Doxepin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0316 | DOXEPIN HYDROCHLORIDE CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 2 | Current NDC, 3 package rows | 20250102_f900bac4-02f2-6bf3-e053-6394a90a2161.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0316-1 | EA - Each | 80425-0316 | 28464baa-062f-4d04-b030-cd4f5b80a754 | 1 | 2023-06-06 |
| 80425-0316-2 | EA - Each | 80425-0316 | 7bca9d58-efc4-4209-8a21-2693fc3e32f3 | 1 | 2023-06-06 |
| 80425-0316-3 | EA - Each | 80425-0316 | f2b33fc2-fff3-4425-b00a-1fb444945861 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Contract Pharmacal Corp. | abbf7078-a012-4e1a-e053-2995a90a792d | 2020-08-06 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Aphena Pharma Solutions - Tennessee, LLC | 10d9eba6-30d1-448a-8d92-a1a02df03303 | 2017-09-05 | Boxed warning, Warnings, Adverse reactions | 1000070 3U9A0FE9N5 |
| PRUDOXIN | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | ca53346b-8ab3-4722-98f6-cf272706d3fa | 2017-06-29 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Zonalon | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | 5f302247-525e-4acc-852b-00eb1d79af4b | 2017-06-14 | Warnings, Adverse reactions | 3U9A0FE9N5 |
| Doxepin Hydrochloride | DOXEPIN HYDROCHLORIDE | Mylan Pharmaceuticals Inc. | b4771ea7-c19b-4182-bb23-c1473ab583fa | 2017-05-24 | Warnings, Adverse reactions | 3U9A0FE9N5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.